Aging increases ovarian cancer growth, metastasis, and immunosuppression that can be alleviated by inhibiting hedgehog signaling
Authors:
- Asha KumariAKAsha Kumari
- Mohamed Halaby ElbahotyMEMohamed Halaby Elbahoty
- Resha RajkarnikarRRResha Rajkarnikar
- Mehri MonavarianMMMehri Monavarian
- Liz Macias QuinteroLQLiz Macias Quintero
- Katherine FuhKFKatherine Fuh
- Daniel J TyrrellDTDaniel J Tyrrell
- Lalita A ShevdeLSLalita A Shevde
- Sudarshan AnandSASudarshan Anand
- Camilla MargaroliCMCamilla Margaroli
Preprint
Abstract
Ovarian cancer incidence and mortality increase with age, yet how aging shapes tumor progression and the immune microenvironment remains poorly defined. Using orthotopic syngeneic models of distinct cellular origins (ovarian surface epithelial and fallopian tube-derived) in young versus aged mice, we show that aged hosts exhibit higher tumor burden, metastasis and ascites. Follicle depletion in young mice did not recapitulate these effects, indicating contributions beyond hormonal decline. Spatial transcriptomics revealed distinct age dependent intratumoral heterogeneity, with Hedgehog signaling enrichment in CD45 + cells from aged tumors, alongside elevated CD206 + tumor-associated macrophages and FoxP3 + regulatory T cells. Pharmacologic Hedgehog inhibition in aged mice suppressed tumor growth, reduced metastasis, and decreased CD206 + macrophages and FoxP3 + T cells while preserving CD8 + T cells. In human ovarian cancer, Hedgehog activation correlated with immunosuppressive and immune checkpoint resistance signatures. We propose Hedgehog inhibition as an immunomodulatory strategy for Hedgehog activated or post menopausal ovarian cancer.Keywords
This publication has 91 references indexed in Scilit:
- Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancerCancer Medicine, 2024
- Age‐related differences in cancer relative survival in the United States: A SEER‐18 analysisInternational Journal of Cancer, 2023
- Age-Associated Risk of 90-Day Postoperative Mortality After Cytoreductive Surgery for Advanced Ovarian CancerJAMA Surgery, 2019
- New insights into the role of EMT in tumor immune escapeMolecular Oncology, 2017
- Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patientsTumor Biology, 2015
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic ActivityCell, 2015
- TLR activation of tumor‐associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cellsEuropean Journal of Immunology, 2014
- Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxelClinical & Experimental Metastasis, 2013
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- Mouse Models in Aging Research2007